DeepHealth

Somerville, MA, United States  All United States companies → Founded 2015
Imaging AI Specialist
Oncology Radiology
Oncology AI Radiology & Imaging AI
N/A (wholly-owned subsidiary of RadNet, Inc.) — N/A (acquired for $34.6M)

Products

Saige-Q
DeepHealth
Oncology AI
Saige-Q is an FDA-cleared AI software by DeepHealth that processes mammograms to prioritize suspicious cases for radiologists, enhancing workflow efficiency and supporting early breast cancer detection.
Saige-Density
DeepHealth
Oncology AI
AI-powered software for automated breast density assessment in mammography, aiding radiologists in consistent BI-RADS classification and reducing subjectivity.
Saige-Density (2.5.0)
DeepHealth
Oncology AI
Saige-Density is an FDA-cleared AI software by DeepHealth for automated breast density assessment in mammography, aiding radiologists in consistent and accurate breast tissue categorization.

See all 4 products →

About DeepHealth

DeepHealth, a wholly-owned subsidiary of RadNet, Inc., stands as a global leader in AI-powered health informatics, dedicated to revolutionizing diagnostic imaging and patient care. The company leverages advanced artificial intelligence to enhance operational efficiency, bolster clinical confidence, and improve the overall delivery of care across diverse healthcare settings. DeepHealth’s comprehensive portfolio integrates cutting-edge AI solutions from several acquired entities, including Aidence, Quantib, and Kheiron Medical, to provide a unified and powerful platform for radiologists and other clinicians.

At the core of DeepHealth’s offerings is its cloud-native operating system, DeepHealth OS, which seamlessly unifies data across the entire clinical and operational workflow. This platform supports a wide array of native clinical AI solutions and services spanning all core imaging modalities, including MR, CT, X-ray, Mammography, and Ultrasound. These solutions are designed to assist in detection, assessment, and monitoring across various health areas such as breast, chest, neuro, prostate, and thyroid health. DeepHealth’s impact is substantial, managing over 24 million imaging studies and facilitating more than 10 million AI-powered diagnoses annually across over 1,800 AI-powered cancer screening sites in the US and Europe, demonstrating a commitment to improving patient outcomes at scale.

What Physicians Need to Know

AI-Powered Imaging Informatics
DeepHealth offers a cloud-native imaging informatics platform that unifies diagnostic workflow, operations management, and remote acquisition (TechLiveu2122), designed to ease workforce pressures and enable efficient radiology team collaboration across sites.
Population Health Suites
They specialize in AI tools for earlier disease detection and stage shifting in breast, chest, neurology, prostate, and thyroid imaging workflows.
Breast Suite
Provides enhanced workflow and diagnostic accuracy in breast cancer detection, including support for 2D/3D mammograms, lesion localization, and suspicion assessment, which has been shown to increase detection rates by 21%.
Prostate Suite
Offers enhanced prostate cancer detection, compatible with leading fusion biopsy systems, featuring automated lesion detection, risk classification, and standardized reporting, leading to a 37% reduction in workflow time for MRI reads.
Chest Suite
Focuses on enhanced nodule detection, reporting, and patient management, with AI-assisted nodule detection significantly improving radiologists' diagnostic accuracy and read efficiency.
Neuro Suite
Aids in assessing and monitoring neurodegenerative changes by automating neuroimaging analysis and quantifying key brain structures for proactive neurological care.
Thyroid Suite
An AI-powered, end-to-end solution for thyroid ultrasound imaging, automating measurements, characterization, and standardizing worksheets and reporting to improve efficiency and consistency.
Operational Efficiency
Leverages AI-embedded automation and analytics to improve utilization, reduce idle time, and support data-driven resource allocation across imaging centers, including their Operations Suite and TechLiveu2122 for remote scanning and radiology management.
Enterprise Imaging
Provides foundational AI-powered informatics to orchestrate diagnostic workflows, including their Diagnostic Suiteu2122 (PACS functionality, enhanced viewer, image management, and smart interpretation) and Operations Suiteu2122 (RIS functionality, real-time workflow management).
Physician Tip

DeepHealth's solutions are designed to empower physicians by improving diagnostic accuracy and consistency through AI-enhanced interpretation and interobserver agreement. They aim to reduce report turnaround times and enhance workflow efficiency by automating repetitive or cognitively heavy tasks, allowing radiologists to focus on complex, high-value decisions and patient care. The platform supports earlier disease detection, leading to more effective and less costly treatments. Physicians benefit from a unified diagnostic workspace that integrates PACS, viewer, reporting, and workflow tools with clinical AI orchestration, providing personalized, AI-powered workspaces with immediate access to necessary information. The AI acts as a 'trusted colleague' to enhance expertise and support expert-level performance.

DeepHealth's core is its cloud-native operating system, DeepHealth OS, which integrates clinical and operational data and workflows through API-based modules. They offer seamless PACS and RIS integration. The Prostate Suite is compatible with leading fusion biopsy systems. DeepHealth works with various OEMs, cloud, AI, and platform partners to unify fragmented tools. Their AI Studio orchestrates over 140 AI algorithms from more than 75 ecosystem partners alongside their own applications within the clinical workflow. DeepHealth also builds on the capabilities of integrated companies like Aidence (lung AI), Quantib (prostate and brain AI), Kheiron Medical, iCAD, Cimar, Gleamer, and Aquila, and leverages RadNet's existing digital health businesses and products, including eRAD Radiology Information.

Products by DeepHealth

4 products in the directory

Saige-Q
DeepHealth
Oncology AI
Saige-Q is an FDA-cleared AI software by DeepHealth that processes mammograms to prioritize suspicious cases for radiologists, enhancing workflow efficiency and supporting early breast cancer detection.
Saige-Density
DeepHealth
Oncology AI
AI-powered software for automated breast density assessment in mammography, aiding radiologists in consistent BI-RADS classification and reducing subjectivity.
Saige-Density (2.5.0)
DeepHealth
Oncology AI
Saige-Density is an FDA-cleared AI software by DeepHealth for automated breast density assessment in mammography, aiding radiologists in consistent and accurate breast tissue categorization.
Saige-Dx
DeepHealth
Oncology AI
AI-powered mammography diagnostic software that assists radiologists in detecting breast cancer earlier and more accurately by identifying suspicious lesions and assigning suspicion levels in mammograms.

Reviews & Opinions

No web reviews on file yet for DeepHealth. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about DeepHealth.

Loading videos...

Videos load interactively. If none appear, search YouTube for DeepHealth →

View all on YouTube

Press & Coverage

GlobeNewswire
DeepHealth Receives Two FDA Clearances Enabling it to Add Cardiovascular Insights and Prior Exam Integration to its AI-Powered Breast Suite
DeepHealth has received FDA 510(k) clearances for Breast Arterial Calcification (BAC) Assessment and prior exam integration into ProFound Pro, now marketed as Mammo Dx, enhancing its AI-powered Breast Suite with cardiovascular insights and improved cancer detection.
2026-06
DeepHealth
DeepHealth Launches Reporting Pro, Bringing AI Automation to Radiology Reporting
DeepHealth announced the commercial launch of Reporting Pro, an AI-powered solution designed to automate radiology reporting by integrating speech recognition, AI-generated clinical findings, measurements, and structured reporting into a seamless workflow.
2026-06
DeepHealth
DeepHealth Achieves Multiple Regulatory Milestones for Neuro, Prostate and LumbarMR
DeepHealth has received CE Marking for its Brain Health and Brain Age solutions within its Neuro Suite, CE Marking for its LumbarMR solution, and FDA 510(k) clearance and CE Marking for the Prostate AI solution within its Prostate Suite.
2026-05
DeepHealth
DeepHealth momentum contributes to RadNet's record Q1 2026 financial results
DeepHealth, RadNet's Digital Health division, reported significant growth in revenue and customer momentum, contributing to RadNet's record first-quarter 2026 financial results with a 51.5% increase in revenue for DeepHealth.
2026-05
DeepHealth
GE HealthCare expands mammography collaboration with RadNet's DeepHealth subsidiary to extend global access to DeepHealth's AI-powered breast cancer screening solutions
GE HealthCare and DeepHealth announced an expanded collaboration to further the innovation, commercialization, and adoption of advanced AI-powered mammography tools globally.
2026-04
DeepHealth
DeepHealth Achieves CE Mark for TechLiveu2122 and Enables AWS Marketplace Deployment, Advancing Global Expansion of Multimodality Vendor-Agnostic Remote Scanning Solution
DeepHealth's FDA-cleared remote imaging and radiology management solution, TechLiveu2122, achieved CE marking, enabling European commercialization and global expansion through AWS Marketplace deployment.
2026-02
DeepHealth
DeepHealth Unveils Next-Generation Imaging Informatics and Clinical AI Solutions at RSNA 2025, Advancing a New Standard of AI-Powered Care
DeepHealth unveiled an expanded portfolio of next-generation imaging informatics and clinical AI solutions at RSNA 2025, aiming to advance a new standard of AI-powered care.
2025-11
Nature Health
Landmark Nature Health Study Demonstrates the Effectiveness of DeepHealth's Novel AI-Powered Breast Cancer Detection Workflow
A study published in Nature Health, the largest real-world analysis of AI-driven breast cancer screening in the US, demonstrated the clinical effectiveness and equitable benefits of DeepHealth's AI technology.
2025-11

Frequently Asked Questions

DeepHealth provides a comprehensive AI-powered health informatics portfolio, centered around its cloud-native DeepHealth OS, which unifies clinical and operational workflows. Their offerings include Diagnostic Suite, Operations Suite, TechLive for remote scanning, and specialized Population Health suites for breast, prostate, chest, neuro, and thyroid health. Additionally, their AI Studio Suite integrates over 140 AI algorithms from more than 75 ecosystem partners to enhance clinical workflows.
DeepHealth, as a subsidiary of RadNet, Inc., adheres to rigorous regulatory standards and has received FDA 510(k) clearances for key products like TechLive and SmartMammo Dx. They utilize Ketryx software for AI-native compliance in regulated medical applications and ensure data security through encryption, localized data centers, and strict adherence to country-specific data rules and regulations, such as keeping EU data within the EU.
Specific enterprise pricing for DeepHealth's AI solutions is not publicly detailed and typically handled through direct engagement. While a separate entity, 'Deep Health India AI,' offers subscription and pay-per-scan models for individual health tracking, this is distinct from DeepHealth's enterprise offerings for healthcare providers. Interested organizations are encouraged to contact DeepHealth directly for a tailored pricing discussion.
While explicit details on their support structure are not publicly outlined, DeepHealth's solutions are deployed in over 800 clinical sites globally, indicating an established support framework. They offer contact information for inquiries and their cloud-native DeepHealth OS is designed to streamline operations for IT teams, suggesting robust system management and integration capabilities.
DeepHealth has established significant strategic partnerships to expand its capabilities and market presence. Notable collaborations include an expanded partnership with GE HealthCare for mammography and ultrasound solutions, and a collaboration with HOPPR to further advance AI in healthcare. They also partner with Incepto to broaden access to their AI-powered medical imaging solutions across Europe.
DeepHealth is a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), a prominent national provider of diagnostic imaging services in the United States. RadNet demonstrates strong financial stability with consistent revenue growth and a network of over 400 imaging centers. This robust corporate backing provides DeepHealth with significant resources and stability as a healthcare AI vendor.
DeepHealth's AI tools have demonstrated real-world efficacy and clinical impact across various applications. For instance, their breast cancer screening solution has the potential to increase cancer detection rates by up to 18% and has shown a 21% increase in detection in a study of over 579,000 women. Their Neuro Suite applications have shown 92% sensitivity in early identification of hippocampal atrophy, and their solutions manage over 15 million exams annually, resulting in more than two million AI-informed diagnoses.

Investors

Who's funded DeepHealth.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.